Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)
Equity Ratio
60.27%
Quarterly · Period ending:
CANF Equity Ratio
Latest reported60.27%period ending
Latest reported60.27%period ending
CANF Quarterly Equity Ratio (19.13% → 60.27%)
Latest values, visible window
High-resolution chart · PNG
CANF equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 60.2731% | |
| 60.2731% | |
| 58.7765% | |
| 58.7765% | |
| 54.1969% | |
| 54.1969% | |
| 59.6053% | |
| 59.6053% | |
| 41.8609% | |
| 41.8609% | |
| 62.4987% | |
| 57.0946% | |
| 62.3096% | |
| 62.9624% | |
| 48.1741% | |
| 58.4606% | |
| 67.0826% | |
| 67.3727% | |
| 71.0117% | |
| 63.7612% | |
| 40.8574% | |
| 55.5486% | |
| 63.7824% | |
| 71.5969% | |
| 71.5313% | |
| 51.4724% | |
| 10.7278% | |
| 60.046% | |
| 61.7619% | |
| 43.3302% | |
| 37.915% | |
| 59.0023% | |
| 59.268% | |
| 59.5511% | |
| 38.9905% | |
| 39.5238% | |
| 39.037% | |
| 47.3392% | |
| 38.0194% | |
| 49.4817% | |
| 55.8792% | |
| 56.0077% | |
| 58.6089% | |
| 45.1304% | |
| 54.8087% | |
| 60.107% | |
| 63.6297% | |
| 51.7789% | |
| 63.4272% | |
| 64.2862% | |
| 57.243% | |
| 32.3984% | |
| 13.5632% | |
| 28.2988% | |
| -76.019% | |
| 16.1873% | |
| 55.4848% | |
| 48.8021% | |
| 55.2304% | |
| 19.1304% |